Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Head and Neck Cancer

Free Subscription 02.02.2026 4 BMC Cancer 4 Br J Cancer 1 Br J Oral Maxillofac Surg 1 Clin Cancer Res 1 Dis Esophagus 2 Head Neck 1 HNO 2 Oral Oncol 2 PLoS One 1 Radiother Oncol 3 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. SCHOFFER O, Kemper M, Gerken M, Bierbaum V, et al
   The effects of certification of head and neck cancer centers on the survival of patients with a head and neck cancer.
   BMC Cancer. 2026;26:132.
   PubMed         Abstract available
   
   
2. ZHU PF, Zhang XF, Mao YX, Zhou P, et al
   Predicting central lymph node metastasis in papillary thyroid carcinoma using a fusion model of vision transformer and traditional radiomics based on dynamic dual-modality ultrasound.
   BMC Cancer. 2026 Jan 26. doi: 10.1186/s12885-025-15153.
   PubMed         Abstract available
   
   
3. ZHANG Y, Zhu H, Yang F, Yang L, et al
   Construction and validation of a prediction model for postoperative complications of elderly patients with locally advanced esophageal squamous cell carcinoma based on POSSUM system and inflammatory factors.
   BMC Cancer. 2026 Jan 27. doi: 10.1186/s12885-026-15559.
   PubMed        
   
   
4. SAKAI H, Shibata A, Miyamoto K, Matsuzawa K, et al
   Practice and impact of selection and centralization for oral cancer services: a scenario analysis.
   BMC Cancer. 2026 Jan 28. doi: 10.1186/s12885-026-15617.
   PubMed        
   
   

   
   Br J Cancer

5. EVANS M, Hurt C, Rhys R, Mahajan A, et al
   Correlation between imaging-detected and pathological extranodal extension in a randomised trial in Human Papillomavirus-positive oropharyngeal cancer.
   Br J Cancer. 2026;134:428-438.
   PubMed         Abstract available
   
   
6. BI J, Liu K, Luo Y, Zhou Y, et al
   Crosstalk of NPY and TGFbeta orchestrates the signaling to facilitate perineural invasion of oral squamous cell carcinoma.
   Br J Cancer. 2026;134:377-390.
   PubMed         Abstract available
   
   
7. MATEOS L, Jimenez-Fonseca P, Gallego J, Lecumberri A, et al
   Does perioperative FLOT increase cure rates in resectable esophageal adenocarcinoma? A mixture cure model analysis.
   Br J Cancer. 2026;134:414-427.
   PubMed         Abstract available
   
   
8. 
   Development and application of quality assurance methods for interventions in randomised controlled trials of surgical oncology: the ROMIO study (a comparison of minimally invasive and open oesophagectomy).
   Br J Cancer. 2026;134:404-413.
   PubMed         Abstract available
   
   

   
   Br J Oral Maxillofac Surg

9. ROSE S, Abdul-Razak M, Samra S, Iqbal F, et al
   How reliable is your pathology report in head and neck cancer?
   Br J Oral Maxillofac Surg. 2026 Jan 18:S0266-4356(26)00008.
   PubMed        
   
   

   
   Clin Cancer Res

10. PRASAD M, Cheng AT, Mayer M, Jansen L, et al
    Genomic enrichment and functional impact of TP53 and CYLD alterations in recurrent and metastatic HPV-associated head and neck cancer.
    Clin Cancer Res. 2026 Jan 28. doi: 10.1158/1078-0432.CCR-25-3972.
    PubMed         Abstract available
    
    

    
    Dis Esophagus

11. CHEN C, Yuan C, Liu Z, Tan L, et al
    Association of immune-related adverse events with survival outcomes in esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy: a national multicenter retrospective cohort study in China.
    Dis Esophagus. 2026;39:doaf137.
    PubMed         Abstract available
    
    

    
    Head Neck

12. WU K, Wei X, Lu M, Wei X, et al
    Safety and Efficacy of Endoscopic Thyroidectomy by Gasless Unilateral Axillary for Papillary Thyroid Carcinoma in Primary Hospitals.
    Head Neck. 2026 Jan 30. doi: 10.1002/hed.70187.
    PubMed         Abstract available
    
    
13. WANG S, Cai H, Huang Z, Zhuge L, et al
    A Prospective Trial on Optimal Extent of Lateral Neck Dissection in pN1 Papillary Thyroid Carcinoma.
    Head Neck. 2026 Jan 26. doi: 10.1002/hed.70116.
    PubMed         Abstract available
    
    

    
    HNO

14. SCHRAMM A, Tisch M, Offergeld C
    [Teaching head and neck ultrasound : Current educational formats and assessment structures and their potential influence on future curriculum development].
    HNO. 2026;74:79-87.
    PubMed         Abstract available
    
    

    
    Oral Oncol

15. ALMEIDA ND, Schrand TV, Sullivan D, Yu H, et al
    Prognostic associations of systemic inflammation response index (SIRI) in patients with head and neck cancer: a systematic review and meta-analysis.
    Oral Oncol. 2026;174:107859.
    PubMed         Abstract available
    
    
16. ZHONG J, Chen H, Yan Z, Xu H, et al
    Refinement of N category in version-nine of AJCC/UICC TNM staging system for nasopharyngeal carcinoma based on the international consensus recommendations for diagnosing extranodal extension.
    Oral Oncol. 2026;174:107866.
    PubMed         Abstract available
    
    

    
    PLoS One

17. OKAMOTO S, Tochii T, Nakada J, Note H, et al
    Association between acute respiratory acidosis and hyperkalemia during esophageal cancer surgery in the prone position: A multicenter retrospective observational study protocol.
    PLoS One. 2026;21:e0337018.
    PubMed         Abstract available
    
    
18. NGUYEN LTH, Vo DT, Thai TT, Ly XQ, et al
    Postoperative swallowing recovery in oral and oropharyngeal cancer: A prospective analysis of functional changes and adjuvant therapy effects.
    PLoS One. 2026;21:e0341116.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

19. ZHANG H, Ding J, Zhang L, Li J, et al
    MRI-based multilevel radiomics and transformer features for predicting radiation-induced carotid artery injury after nasopharyngeal carcinoma radiotherapy: A multicenter study.
    Radiother Oncol. 2026 Jan 24:111390. doi: 10.1016/j.radonc.2026.111390.
    PubMed         Abstract available
    
    

    
    Thyroid

20. GUI L, Zhu H, Tang L, Zhu Y, et al
    Anlotinib Plus Sintilimab for BRAF(V600E) Negative Unresectable or Metastatic Anaplastic Thyroid Carcinoma: A Single-Center, Single-Arm, Phase 2 Trial.
    Thyroid. 2026 Jan 24:10507256261416838. doi: 10.1177/10507256261416838.
    PubMed         Abstract available
    
    
21. CIAMPI R, Casalini R, Ramone T, Mori S, et al
    Liquid Biopsy-Based RET Mutation Profiling to Guide RET Inhibitor Treatment in Sporadic Medullary Thyroid Carcinoma May Be Useful in Cases with High Tumor Burden and Progressive Disease.
    Thyroid. 2026 Jan 24:10507256261416836. doi: 10.1177/10507256261416836.
    PubMed         Abstract available
    
    
22. COMISKEY DF JR, Liyanarachchi S, Wu J, Sheikh MS, et al
    Identification of Rare Noncoding Variants in Familial Nonmedullary Thyroid Carcinoma.
    Thyroid. 2026 Jan 27:10507256251408827. doi: 10.1177/10507256251408827.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.